Carl L. Gordon - Feb 8, 2023 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Signature
/s/ Neil Lerner, attorney-in-fact
Stock symbol
CMPX
Transactions as of
Feb 8, 2023
Transactions value $
$0
Form type
4
Date filed
2/9/2023, 03:28 PM
Previous filing
Dec 28, 2022
Next filing
Feb 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPX Stock Option (Right to Buy) Award $0 +60K $0.00 60K Feb 8, 2023 Common Stock 60K $3.93 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest over 48 substantially equal monthly installments starting March 8, 2023.
F2 The Reporting Person is a member of OrbiMed Advisors LLC ("OrbiMed Advisors"). Pursuant to an agreement with OrbiMed Advisors, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors and OrbiMed Capital GP V LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments V-KA, LP.